Amadoriase having enhanced dehydrogenase activity
US-2017355967-A1 · Dec 14, 2017 · US
HbA1c dehydrogenase
US11111517B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11111517-B2 |
| Application number | US-201716094924-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 21, 2017 |
| Priority date | Apr 22, 2016 |
| Publication date | Sep 7, 2021 |
| Grant date | Sep 7, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention provides an HbA1c dehydrogenase that is capable of directly acting on hemoglobin A1c and is less likely to be influenced by oxygen concentration and a method for measurement and a kit of assay reagents using such HbA1c dehydrogenase. The HbA1c dehydrogenase having dehydrogenase activity and capable of directly acting on HbA1c is obtained by substitution of one or more amino acid residues at positions corresponding to positions 280, 269, 54, 241, and 267 of the amadoriase that is capable of directly acting on hemoglobin A1c and is derived from, for example, the genus Coniochaeta. This invention also provides a method for measurement of HbA1c, a kit of assay reagents, and a sensor using such HbA1c dehydrogenase. Such HbA1c dehydrogenase is capable of directly acting on hemoglobin A1c and has lowered oxidase activity and/or enhanced dehydrogenase activity. This not only eliminates the need for treatment of hemoglobin A1c with a protease but also enables the use of an electron mediator in the measurement of HbA1c, thereby reducing effects due to oxygen concentration, and enables HbA1c measured with high sensitivity.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for measurement of hemoglobin A1c in a sample comprising contacting an HbA1c dehydrogenase directly acting on hemoglobin A1c with hemoglobin A1c in a sample and measuring a reduced electron mediator that is not hydrogen peroxide generated by the action or an oxidized electron mediator that is not oxygen consumed by the action, wherein a protease is not applied to the sample, and wherein the measurement is solely based on measuring the dehydrogenase activity of the HbA1c dehydrogenase. 2. The method for measurement according to claim 1 , wherein said measurement is an electrochemical measurement using an HbA1c dehydrogenase, an enzyme electrode comprising HbA1c dehydrogenase or an enzyme sensor comprising, as a working electrode, said enzyme electrode, and an electron mediator that is not oxygen or wherein said measurement is an absorbance measurement using HbA1c dehydrogenase, a colorimetric substrate, and an electron mediator that is not oxygen.
Assignees
Inventors
Classifications
- C12Q1/32Primary
involving dehydrogenase · CPC title
Lyases (4.) · CPC title
Systems (G01N27/27 takes precedence) · CPC title
Apparatus specially designed for the use of free, immobilised, or carrier-bound enzymes, e.g. apparatus containing a fluidised bed of immobilised enzymes · CPC title
Physical analysis of biological material · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11111517B2 cover?
- This invention provides an HbA1c dehydrogenase that is capable of directly acting on hemoglobin A1c and is less likely to be influenced by oxygen concentration and a method for measurement and a kit of assay reagents using such HbA1c dehydrogenase. The HbA1c dehydrogenase having dehydrogenase activity and capable of directly acting on HbA1c is obtained by substitution of one or more amino acid …
- Who is the assignee on this patent?
- Kikkoman Corp
- What technology area does this patent fall under?
- Primary CPC classification C12Q1/32. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).